Who is sponsoring NCT04180631?

NCT04180631 is sponsored by Seoul National University Hospital.

What drugs are being tested in NCT04180631?

Interventions in NCT04180631: Quantitative ultrasound imaging parameter (QUS).

What condition does NCT04180631 study?

NCT04180631 studies Hepatic Steatosis.

Is NCT04180631 still recruiting?

NCT04180631 is currently completed. Last updated 19 August 2021.

Last reviewed 2021-08-19 · How we verify

NCT04180631

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Quantitative US for Hepatic Steatosis

Completed NA Last updated 19 August 2021

What this trial tests

NA trial testing Quantitative ultrasound imaging parameter (QUS) in Hepatic Steatosis in 124 participants. Completed in 19 January 2020.

Timeline

5 March 2019

Primary endpoint
19 January 2020

19 January 2020

Quick facts

Lead sponsor	Seoul National University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	124
Start date	5 March 2019
Primary completion	19 January 2020
Estimated completion	19 January 2020
Sites	1 location across South Korea

Drugs / interventions tested

Quantitative ultrasound imaging parameter (QUS)

Conditions studied

Hepatic Steatosis — all drugs for Hepatic Steatosis →

Sponsor

Seoul National University Hospital

Who can join

18 and older, any sex, with Hepatic Steatosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the diagnostic performance of quantitative ultrasound imaging parameter for the assessment of hepatic steatosis in patients with non-alcoholic fatty liver disease using magnetic resonance imaging proton density fat fraction (MRI-PDFF) and MR spectroscopy as the reference standard.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Quantitative Ultrasound Radiofrequency Data Analysis for the Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Using Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.
Jeon SK, Lee JM, Joo I, Park SJ. · · 2021 · cited 46× · PMID 33739636 · DOI 10.3348/kjr.2020.1262
Two-dimensional Convolutional Neural Network Using Quantitative US for Noninvasive Assessment of Hepatic Steatosis in NAFLD.
Jeon SK, Lee JM, Joo I, Yoon JH, et al · · 2023 · cited 40× · PMID 36594835 · DOI 10.1148/radiol.221510

Verify or expand the search:

Other recruiting trials for Hepatic Steatosis

Currently open trials in the same condition.

NCT07481734 — Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study) · Phase 2 · recruiting
NCT06940375 — Incidence of Liver Disease-Related Outcomes in People With HIV · recruiting
NCT07192159 — Quantitative Ultrasound(DeepUSFF) vs MRI-PDFF for Liver Fat Assessment in MASLD · NA · recruiting
NCT06891365 — Multiple Dose Study for a New Medication to Potentially Treat Liver Diseases · Phase 1 · recruiting
NCT06694012 — Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2 · recruiting

Other Seoul National University Hospital trials

Trials by the same sponsor.

NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04180631 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
Last refreshed: 19 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04180631.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing